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Background: Prepulse inhibition (PPI) of the startle response refers to the ability of a weak prestimulus to transiently inhibit the
response to a closely following strong sensory stimulus. This effect is reduced in a number of disorders known to be associated
with impaired gating of sensory, cognitive or motor information. The aim of this study was to investigate PPI deficit in relation to
the dimensions of auditory hallucinations in patients with schizophrenia or schizoaffective disorder.
Method: PPI of the acoustically elicited eye blink startle response was measured electromyographically in 62 patients with
schizophrenia (n=55) or schizoaffective disorder (n=7) (26 of 62 with current auditory hallucinations) and 22 healthy participants
matched, on average, to age and sex of the patient group.
Results: Patients, as a group, showed reduced PPI compared to healthy participants. The presence of auditory hallucinations was
associated with a marked PPI deficit if the patients felt that they had no control over their occurrence and that they were unable to
dismiss them. Hearing voices with a high degree of negative content was associated with high mean startle amplitude in patients
with current auditory hallucinations.
Conclusions: Although auditory hallucinations in patients with schizophrenia are theorised to result from impaired monitoring of
inner speech, the inability to consciously ignore them appears to be associated with a gating deficit. Hearing voices with negative
content is associated with hyper-startle responding, possibly because such voices are threatening and thus provoke anxiety.
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A key feature of schizophrenia is the inability to
screen out irrelevant sensory input (Braff, 1993).
Prepulse inhibition (PPI) of the startle response provides
a valuable tool to study this feature (Geyer et al., 1990).
PPI refers to a reliable reduction in the amplitude of the
startle response to a strong sensory stimulus, the pulse,
186 V. Kumari et al. / Schizophrenia Research 101 (2008) 185–194if this is preceded shortly (30–500 ms) by a weak
stimulus, the prepulse (Graham, 1975).
PPI is found to be reduced in a number of neuropsy-
chiatric disorders that are associated with impaired
control of sensory (e.g. schizophrenia; Braff et al., 1978,
review 2001; Kumari et al., 2005, 2007a,b; Meincke
et al., 2004; Swerdlow et al., 2006), cognitive (e.g.
obsessive compulsive disorder, Swerdlow et al., 1993;
post-traumatic stress disorder, Ornitz and Pynoos,
1989; Grillon et al., 1996) or motor information (e.g.
Huntington disease, Swerdlow et al., 1995). Within
patients with schizophrenia PPI is reported to show
weakly negative or no associations with positive or
negative symptoms using ratings from general psychia-
tric symptom scales (review, Braff et al., 2001;
Swerdlow et al., 2006) and relatively stronger negative
correlations with thought disorder (Perry and Braff,
1994; Perry et al., 1999). PPI also correlates negatively
with distractibility (Karper et al., 1996; Kumari et al.,
2007b) and positively with functional status (Swerdlow
et al., 2006) in schizophrenia.
Auditory hallucinations are common in schizophre-
nia and theorised to result from an impaired monitoring
of inner speech (Frith, 1992). Auditory hallucinations
are known to vary on a number of important dimensions
other than frequency and severity, such as controllability
and distress. Previous studies have noted associations
between the frequency of auditory hallucinations and
reduced suppression of irrelevant thoughts and mem-
ories (Waters et al., 2003; Badcock et al., 2005), and
increased cognitive intrusions (Morrison and Baker,
2000). The inability to suppress intrusive memories and
thoughts are considered to be the behavioural correlates
of deficient PPI in patients with post-traumatic stress
disorder (Grillon et al., 1996) and obsessive compulsive
disorder (Swerdlow et al., 1993), respectively.
No previous study to our knowledge has examined the
influence of auditory hallucinations and its dimensions
on PPI of the acoustic startle response in schizophrenia.
Given earlier mentioned findings on the behavioural
correlates of auditory hallucinations in schizophrenia
(Grillon et al., 1996; Waters et al., 2003; Badcock et al.,
2005) and the postulated link between PPI deficit and
the inability to suppress intrusive memories and
thoughts in patients with post-traumatic stress disorder
(Grillon et al., 1996) and obsessive compulsive disorder
(Swerdlow et al., 1993), perceived uncontrollability of
voices may be associated with a marked PPI deficit in
psychotic individuals.
In this study we examined PPI of the acoustic startle
reflex in relation to the symptom of auditory hallucina-
tions in patients with schizophrenia or schizoaffectivedisorder. Specifically, we tested the hypothesis that
reduced controllability of voices would be associated
with a more severe PPI deficit. The patient group, on
average, was expected to show reduced PPI compared to
the control group.
2. Materials and methods
2.1. Participants
The study sample included 62 patients with a
diagnosis of schizophrenia (n=55) or schizoaffective
disorder (n=7) who had agreed to take part in a
longitudinal study to examine the biological effects of
responsiveness to cognitive behaviour therapy (CBT)
adjunct to their usual treatment (the data reported here
were collected as part of their baseline assessments prior
to any CBT) and 22 healthy participants. The healthy
group was matched, on average, to age and sex of the
patient group.
All patients were (i) recruited from the South London
and Maudsley NHS Foundation Trust, (ii) on stable
doses of antipsychotic medication for at least three
months prior to taking part, (iii) in a chronic phase of the
illness, and (iv) living in the community or long-stay/
rehabilitation wards. Healthy participants were recruited
from the local community.
Table 1 shows demographic and clinical character-
istics of the study groups. The patients who reported
hearing voices in the week preceding the clinical and
psychophysiological assessments were classified as the
group with current auditory hallucinations (AH+);
remaining patients were classified as the group without
current auditory hallucinations (AH−). The AH− group
reported no auditory hallucinations when examined
by the clinician and the researcher (in two separate
sessions).
The study was approved by the South London and
Maudsley NHS Foundation Trust and the Institute of
Psychiatry research ethics committee. All participants
provided written informed consent and were compen-
sated for their time and travel.
2.2. Diagnoses and clinical assessments
Clinical diagnoses were made by an experienced
psychiatrist (DF) using the Structured Clinical Interview
for DSM-IV (First et al., 1995). Symptoms in patients
were rated by the same psychiatrist using the Positive
and Negative Syndrome scale (PANSS) (Kay et al.,
1987). The patients with current auditory hallucinations
were further rated using the auditory hallucinations
Table 1
Demographics and clinical characteristics of study groups
Healthy participants
(n=22)
Patients with current auditory
hallucinations (n=26)
Patients with previous or no
hallucinations (n=36)
Mean (s.d.) Mean (s.d.) Mean (s.d.)
Demographics
Age (years) 35.23 (12.72) 38.73 (9.08) 38.81 (10.70)
Predicted IQ ( aNART) 115.23 (8.47) 109.81 (9.13) 105.37 (8.47)
Years of education 15.18 (2.75) 13.46 (2.45) 13.68 (2.59)
Sex distribution (male/female) 16/6 18/8 28/8
Smokers (n) 4 12 22
b10 cigarettes/daily 1 2 7
10–20 cigarettes/daily 2 7 7
N21 cigarettes/daily 1 3 8
Clinical Characteristics
Diagnoses 25 schizophrenia (24 paranoid,
1 catatonic), 1 schizoaffective disorder
30 schizophrenia (27 paranoid,
3 residual), 6 schizoaffective disorder
Age at onset of psychotic
symptoms (years)
21.62 (6.56) 25.14 (8.63)
Duration of illness (current age minus
age at onset of symptoms)
17.12 (10.06) 13.67 (10.41)
bPositive Symptoms 19.92 (3.73) 14.28 (4.12)
bNegative Symptoms 20.11 (3.97) 17.22 (4.67)
bGeneral Psychopathology 35.46 (6.98) 31.53 (6.02)
Total b PANSS Scores 75.50 (11.71) 63.03 (12.62)
Medication (n) 19 patients on atypical antipsychotics,
2 patients on typical antipsychotics,
4 patients on both atypical and typical
antipsychotics and 1 patient medication
non-compliant.
28 patients on atypical antipsychotics,
7 patients on typical antipsychotics,
1 patient on both atypical and
typical antipsychotics.
a NART: National Adult Reading Test (Nelson and Willison, 1991).
b Positive and Negative Syndrome Scale (PANSS; Kay et al., 1987).
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(PSYRATS, Haddock et al., 1999) by a doctoral level
psychologist (MC) who was not involved in psycho-
physiological data collection. The auditory hallucina-
tions subscale of the PSYRATS scale has 11 items:
frequency, duration, location, loudness, beliefs about the
origin of voices, amount of negative content, degree of
negative content, amount of distress, intensity of
distress, disruption to life and controllability of voices.
All items are rated on a five-point scale. The PSYRATS
scales have shown excellent inter-rater reliability and
validity in both chronic (Haddock et al., 1999) and first-
episode schizophrenia samples (Drake et al., 2007). The
positive symptom items of other clinical rating scales,
namely, Scale for the Assessment of Positive Symptoms
(SAPS; Andreasen, 1984) and PANSS (Kay et al.,
1987), are reported to reflect more objective aspects of
PSYRATS ratings of auditory hallucinations (frequency
and duration items, r values N0.30) but not the sub-
jective aspects (r values between −0.01 and 0.23 for
location, loudness, amount of negative content, degreeof negative content, amount of distress, intensity of
distress, and controllability) (Steel et al., 2007).
All potential healthy participants were screened
using a semi-structured interview (First et al., 2002)
and included only if they did not have a history of
mental illness, and drug and alcohol abuse and were not
on a regular medical prescription.
In addition, predicted IQ was measured in all
participants using the National Adults Reading test
(Nelson andWillison, 1991) for sample characterization.
2.3. Psychophysiological data collection and scoring
A commercially available human startle response
monitoring system (Mark II, SR-Lab, San Diego,
California) was used to generate and deliver the acoustic
stimuli, and to record and score the electromyographic
(EMG) activity for 250 ms starting from the onset of the
acoustic startle stimulus.
Acoustic stimuli were presented to participants bin-
aurally through headphones. The pulse-alone stimulus
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and the prepulse stimulus a 20-ms presentation of 85-dB
(A) white noise, both over 70-dB (A) continuous back-
ground noise. The noise levels were calibrated using the
continuous noise, checked on a monthly basis, and re-
calibrated if required. The session began with a 5 min
acclimatization period consisting of 70 dB (A) continuous
white noise. During the experiment, participants received
four blocks of 12 trials each, after an initial pulse-alone
trial; each block consisted of three pulse alone trials, three
prepulse trials with a 30-ms prepulse-to-pulse (onset
to onset) interval, three prepulse trials with a 60-ms
prepulse-to-pulse interval, and three prepulse trials with a
120-ms prepulse-to-pulse interval presented to partici-
pants in a pseudorandom order with a mean inter-trial
interval of 15 s (range 9–23 s).
The experimental procedures for recording and scoring
the startle reflexes were identical to those reported pre-
viously (e.g. Kumari et al., 2000, 2005, 2007a). Eye blink
component of the startle was indexed by recording EMG
activity of the orbicularis oculi muscle directly beneath
the right eye, by positioning two miniature silver/silver
chloride electrodes. Recorded EMG activity was band-
pass filtered, as recommended by the SR-Lab. A 50-hz
filter was used to eliminate the 50-Hz interference. The
EMG data were at first inspected on a trial-to-trial basis
offline and then scored using the analytic programme of
this system for response amplitude (in arbitrary analogue-
to-digital units; one unit=2.62 μV) and latencies to
response onset and peak. Responses (b4%) were rejected
if the onset and peak latencies differed bymore than 95ms
or when the baseline values shifted bymore than 50 units.
PPI was computed for each participant separately for
each trial type as (a−b /a)×100, where “a”=pulse-alone
amplitude and “b”=amplitude over prepulse trials.
Percent of PPI, rather than absolute amount of PPI (i.e.
arithmetic difference between pulse-alone and prepulse
trials), was used since this procedure eliminates the in-
fluence of individual differences in startle responsiveness.
Psychophysiological data were scored blind to diagnosis
and group membership.
Participants were told that the experiment was to
measure their reaction to a number of noise-bursts, but
no specific instructions were given on whether to attend
or ignore them. They were requested to keep their eyes
open during the experiment. There was no explicit
restriction on smoking intake prior to testing but care
was taken not to take participants to the startle lab-
oratory for about 30 min after they had a cigarette, in
order to prevent a state of smoking withdrawal or a
heavy intake during the testing session that may
transiently affect PPI (Kumari et al., 2001).2.4. Data analysis
The demographic and clinical variables were ana-
lysed using one-way analysis of variance (ANOVA)with
planned comparisons (LSD) to compare the three groups
against one another, or using independent sample t-tests,
as appropriate.
To examine possible group differences in the am-
plitude and habituation of the startle response over pulse-
alone trials, the data were subjected to a 3 [Group:
controls, AH+, patients, AH− patients]×4 (Block: 4
blocks, each consisting of three trials) ANOVA, with
Group as a between-subjects and Block as a within-
subjects factor with planned comparisons. The possible
associations of mean pulse-alone amplitude to pulse-
alone trials over the entire session with age, duration of
illness and PANSS symptom dimensions were examined
across the entire sample using Pearson's correlations,
and with dimensions of auditory hallucinations in the
AH+ group using Spearman rank correlations. A sig-
nificant correlation between hearing voices with a high
degree of negative content and high mean startle
amplitude in the AH+ group (see Results) was further
examined by correlations between scores on individual
items of the general psychopathology scale and mean
pulse-alone amplitude using Spearman rank correla-
tions. This enabled us to determine whether the observed
associated may be mediated by heightened anxiety/
tension (assessed with PANSS G2, anxiety, and G4,
tension items) since anxiety states are well known to
potentiate the startle response (review, Grillon, 2002).
To examine group differences in PPI, PPI (%) scores
were subjected to a 3 (Group, as above)×3 (Trial type:
30-ms, 60-ms and 120-ms prepulse trials) ANOVA, with
Group as a between-subjects and Trial type as a within-
subjects factor, with planned comparisons. The relation-
ships of PPI scores to the PANSS symptom dimen-
sions and other clinical and demographic variables were
examined across the entire sample using Pearson's
correlations. Possible associations between the dimen-
sions of auditory hallucinations and PPI in the AH+
group were examined using Spearman rank correlations.
Given that cigarette smoking (Kumari et al., 2001;
George et al., 2006) and antipsychotic drugs (review,
Kumari and Sharma, 2000; Leumann et al., 2002; Oranje
et al., 2002; Kumari et al., 2002, 2007b; Swerdlow et al.,
2006) influence PPI in schizophrenia, any association
found between PPI and controllability dimension of
auditory hallucinations was re-evaluated using partial
correlations controlling for the number of cigarettes
smoked per day (0 for non-smokers) and the type of
antipsychotic medication (atypical, typical, both).
Table 2
Mean (standard error of the mean, s.e.m.) response amplitudes (in
analogue-to-digit units; 1 unit=2.62 μV) over the four blocks of three










Startle amplitude Mean (s.e.m.) Mean (s.e.m.) Mean (s.e.m.)
Block 1 256.18 (44.87) 254.49 (41.28) 239.82 (35.08)
Block 2 225.05 (33.90) 176.94 (31.18) 180.88 (26.50)
Block 3 188.30 (33.20) 154.55 (30.54) 161.80 (25.95)
Block 4 176.80 (27.51) 131.01 (25.31) 134.11 (21.51)
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(Group)×4 (Trial Type: pulse-alone and 3 prepulse
trials) ANOVA with Group as a between-subjects and
Trial Type as a within-subjects factor. Following a
significant Group effect in peak latency (see Results),
this measure was further examined using Pearson's
correlations in relation to clinical and demographic
variables, and then using multiple regression models
where more than one variable showed a significant
association. The dimensions of auditory hallucination
were also examined in association with the latency
measure using the Spearman rank order correlations in
the AH+ group. Following the observation of different
clinical correlates of PPI and latency to response peak in
our patient sample (see Results), we performed
Pearson's correlations between PPI and latency to re-
sponse peak at each prepulse type first in the entire
patient sample, and then separately in the AH− and AH+
groups. We further evaluated any significant latency-PPI
associations using partial correlations controlling for the
duration of illness and PANSS symptom ratings and
the controllability dimension of auditory hallucinations
(AH+ group only).
All analyses were performed by SPSS windows
(version 15). Alpha level for testing significance of
effects was p=0.05 unless stated otherwise. Sex was
initially entered as a between-subjects factor in all
ANOVAs but subsequently removed because it did not
interact with Group in any analyses. Prior to conducting
the described analysis procedures, the data were
examined to ensure that statistical assumptions required
for these analyses were met in this data set.
3. Results
3.1. Clinical and behavioural measures
As shown in Table 1, the three study groups did not
differ in age (Fb1). Both AH+ and AH− patient groups,
compared to the control group, had fewer years in
education [F(2,84)=3.16, p=0.048; AH+ vs controls:
p=0.02; AH− vs controls; p=0.03] and lower predicted
IQ [F(2,84)=7.16, p=0.001; AH+ vs controls: p=0.03
AH− vs controls; p=0.001].
The AH+ and AH− groups were not significantly
different in age at the onset of psychotic symptoms
(as self-reported and verified with relatives and clini-
cal records as much as possible) or the duration of ill-
ness (current age minus the age at onset of psychotic
symptoms). The AH+ group, however, had more se-
vere symptoms on the PANSS than the AH− group
[positive symptoms: t (60)=5.53, pb0.001; negativesymptoms: t=2.56, p=0.01; general psychopathology:
t=3.96, pb0.001].
3.2. Startle measures
3.2.1. Amplitude and habituation
The three groups showed comparable amplitude and
habituation of the startle response over pulse-alone
trials as demonstrated by a significant effect of Block
[F(3, 243)=25.159; pb0.001) showing habituation of
the startle response over four blocks (Linear F(1, 81)=
36.22, pb0.001) in all groups, but no Group or Group x
Block effect (Fb1). Mean (s.e.m.) startle amplitudes for
blocks 1–4 in the control and two patient groups are
presented in Table 2.
Mean pulse-alone amplitude did not correlate sig-
nificantly with age, duration of illness or PANSS symp-
tom dimensions across the entire patient sample, but
correlated positively with hearing voices with a high
degree of negative content in the AH+ group (rho=0.437,
p=0.04). Ratings on the PANSSG2 (anxiety: rho=0.322,
p=0.008) and the PANSS G4 items (tension: rho=0.278,
p=0.029) also correlated positively with mean pulse-
alone amplitude across the whole sample (for all other
general psychopathology items: pN0.05) and (with
somewhat larger rho values) when the analyses was
restricted to theAH+ group only (PANSSG2: rho=0.339,
p=0.09; PANSS G4: rho=0.461, p=0.018).
3.2.2. PPI
There was, as expected, a significant effect of Group
[F(2, 1)=4.34, p=0.016]. Planned comparisons showed
less PPI in both patient groups relative to the control
group (AH+ vs. controls: p=0.01; AH− vs. controls;
p=0.01). The two patient groups were not significantly
different from each other (Fig. 1). There was a significant
effect of Trial type [F(2, 62)=44.68; pb0.001], reflect-
ing a linear increase in PPI from 30-ms through 60-ms to
Fig. 2. Association between control over hearing voices and PPI at
120-ms prepulse-to-pulse interval in patients with current auditory
hallucinations.
Fig. 3. Peak latency in groups of controls and patients with and without
auditory hallucinations. Vertical lines demonstrate +1 standard error of
the mean.
Fig. 1. PPI (% inhibition) in groups of controls and patients with (AH-
present) and without auditory hallucinations (AH-absent). Vertical
lines demonstrate +1 standard error of the mean.
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Fb1).
Supporting our hypothesis, self-perceived lack of
control over hearing voices was significantly associated
with lower 120-ms (rho=0.636, pb0.001; Fig. 2) and
60-ms PPI (rho=0.467, p=0.02). This relationship was
in the same direction for 30-ms PPI but failed to reach
significance (rho=−0.283, p=0.16). The correlations
between self-perceived lack of control over hearing
voices and lower PPI were very similar and significant
after we controlled for the number of cigarettes smoked
daily (120-ms PPI: r=0.689, pb0.001; partial correla-
tion=0.671, pb0.001; 60-ms PPI: r=0.423, p=0.03,
partial correlation=0.443, p=0.027) and the type of
antipsychotic treatment (120-ms PPI: partial correla-
tion=0.694, pb0.001; 60-ms PPI: partial correla-
tion=0.403, p=0.05). Demonstrating the specificity of
controllability-PPI association, controllability dimen-
sion did not correlate (as mentioned earlier) with pulse-
alone amplitude over the entire session, and no other
dimension of auditory hallucinations correlated with PPI
at any of three intervals (all pN0.20).
No symptom dimension of the PANSS correlated
with PPI across the entire sample (all pN0.20). Age,
predicted IQ, and number of years in education also did
not significantly correlate with PPI at any of the three
intervals (all pN0.20).
3.2.3. Peak latency
Therewas a significantmain effect ofGroup [F(2, 81)=
3.78, p=0.03] indicating significantly longer latencies
in the AH+ group, relative to the control group, over all
trial types (p=0.007). Although the AH− patients did
not differ significantly from controls, they also showedsomewhat prolonged latencies (p=0.11) and were not
significantly different (p=0.18) from the AH+ patients
(Fig. 3). The main effect of Trial Type, as found in most
previous PPI studies (reviewed, Braff et al., 2001;
Kumari and Ettinger, 2005), was significant [F(3, 243)=
8.78, pb0.001] indicating latency facilitation by prepulse
trials, especially with the 30-ms and 60-ms prepulse trials
[linear F(1,81)=4.06, p=0.05; quadratic F(1,81)=2680,
pb0.001] (Fig. 3). The Trial type×Group interaction
was not significant (p=0.17).
The results of correlational analyses (presented in
Table 3) revealed that older age and a longer duration of
illness most strongly correlated with longer latencies
over various trial types. Negative symptoms and general
psychopathology, but not positive symptoms, were also
correlated with longer latencies over various prepulse
trials (Table 3).
When examined in the entire patient sample, the
multiple regression model for the latencies to pulse-
alone amplitude (including age and the duration of
Table 3
Correlations (Pearson's r) between peak latency and demographic and clinical variables in patients with current auditory hallucinations and for the
entire patient sample (in parentheses)
Pulse-alone 30-ms 60-ms 120-ms
Years of education −0.050 (0.151) 0.029 (0.023) −0.060 (−0.046) 0.171 (−0.025)
Predicted IQ ( aNART) −0.093 (−0.069) −0.144 (−0.151) −0.059 (0.093) 0.0176 (0.134)
Age 0.345 (0.272⁎) 0.325 (0.211) 0.289 (0.195) 0.398⁎ (0.100)
Age at onset of psychotic symptoms 0.147 (0.008) −0.219 (0.116) −0.076 (−0.240) −0.238 (0.239)
Duration of illness 0.215 (0.269⁎) 0.438⁎ (0.292⁎) 0.311 (0.373⁎⁎) 0.513⁎⁎(0.280⁎⁎)
bPositive symptoms −0.149 (−0.022) 0.015 (0.030) 0.082 (0.136) 0.056 (0.124)
bNegative symptoms 0.373 (0.190) 0.389⁎ (0.187) 0.335 (0.206) 0.068 (0.238)
bGeneral psychopathology 0.179 (0.140) 0.430⁎ (0.237) 0.254 (0.259⁎) 0.034 (0.184)
Total bPANSS scores 0.186 (0.124) 0.424⁎ (0.189) 0.291 (0.244) 0.062 (0.214)
⁎pb0.05, ⁎⁎pb0.01.
a NART: National Adult Reading Test (Nelson and Willison, 1991).
b Positive and Negative Syndrome Scale (PANSS; Kay et al., 1987).
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2.78, p=0.07; R=0.29; R2 =0.086]. The multiple
regression model for latencies to 60-ms prepulse trials
(including the duration of illness and the general
psychopathology score) was significant [F(2,61)=
6.80, p=0.002; R=0.433; R2 =0.188] with the duration
of illness emerging as the only significant predictor
(t=2.96, p=0.004). As shown in Table 3, only the
duration of illness correlated significantly positively
with latencies to the 30-ms and 120-ms prepulse trials
(thus no multiple regression analyses).
When examined exclusively in the AH+ group, the
multiple regression model for latencies to 30-ms
prepulse trials (including the duration of illness, nega-
tive symptoms, general psychopathology) was signifi-
cant [F(3,25)=5.45, p=0.006; R=0.655; R2 =0.428];
the duration of illness emerged as the only significant
predictor (t=2.64, p=0.01). The multiple regression
model for latencies to 120-ms prepulse trials (the
duration of illness and age) was also significant [F
(2,25)=4.12, p=0.03; R=0.513; R2 =0.264]; the dura-
tion of illness was the stronger of the two (age and the
duration of illness) predictors. The dimensions of
auditory hallucination did not show significant or
consistent associations with the latency measure.
When examined across the entire patient sample,
latencies to peak did not correlate significantly with PPI
at 30-ms (r=−0.189) or 60-ms intervals (r=−0.072) but
correlated significantly negatively with PPI at 120-ms
intervals (r=−0.257, p=0.043). This effect was more
marked and significant only in AH+ group when we
examined these correlations separately in the AH− and
AH+ groups. We found that latencies to peak did not
correlate significantly with PPI at 30-ms (AH+ group:
r=−0.242; AH− group: r=−0.169) or 60-ms intervals(AH+ group: r=−0.158; AH− group: r=−0.018) in
either group, but correlated significantly negatively with
PPI at 120-ms intervals in the AH+ group (AH+ group:
r=−0.436, p=0.043; AH− group: r=−0.138). The
longer latencies-lower PPI association in the AH+ group
remained significant after controlling for ratings on
the controllability dimension of the PSYRATS (partial
r=−0.441, p=0.027) and positive symptoms (par-
tial r=−0.439, p=0.028), negative symptoms (partial
r=−0.437, p=0.029) and general psychopathology
scores on the PANSS (partial r=−0.438, p=0.029),
but became non-significant after controlling for the
duration of illness (partial r=−0.30, p=0.14).
Age was not significantly associated with latencies to
pulse-alone or prepulse trials in the control group (all
pN0.35, r values from 0.07 to 0.20).
4. Discussion
Our results confirm a large number of previous
reports of reduced PPI, on average, in patients with
schizophrenia compared to healthy controls (Braff et al.,
1978, review 2001; Kumari et al., 2000, 2005, 2007a,b;
Meincke et al., 2004; Swerdlow et al., 2006). They also
reveal, for the first time, that in schizophrenia patients
(a) the presence of auditory hallucinations is associated
with a deficit in PPI if the patients feel that they have no
control over their occurrence, (b) hearing voices with a
high degree of negative content is associated with hyper-
startling, and (c) a longer duration of illness is more
strongly associated than age with longer latencies to
prepulse trials.
Of all neuropsychiatric disorders associated with
impaired sensorimotor gating, PPI deficit has been most
intensively studied in schizophrenia. As noted earlier in
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this population is reported to be associated with thought
disorder (Perry and Braff 1994; Perry et al., 1999) and
distractibility (Karper et al., 1996), but found to be
uncorrelated, or only weakly correlated, with positive
symptoms (reviews, Braff et al., 2001 and Kumari and
Ettinger, 2005; Swerdlow et al., 2006) assessed on the
commonly used rating scales, namely, the PANSS (Kay
et al., 1987) and the Scale for the Assessment of Positive
Symptoms (Andreasen, 1984). The relationship between
PPI and the subjective experiences of lack of control
over hearing voices (i.e. the subjective awareness of
cognitive disturbances rather than the principal feature
of positive symptoms per se) may not be captured using
the SAPS or the PANSS ratings of auditory hallucina-
tions since they do not reflect the subjective aspects of
auditory hallucinations (Steel et al., 2007).
Our results indicate that it is not the presence or
absence of voices which is related to impaired PPI, but
the feeling of having no control over their occurrence
and being unable to dismiss them. This association may
provide insight into possible mechanisms for recent
observations of a positive relationship between PPI and
functional status, but no significant association between
PPI and positive or negative symptoms in the same
sample (Swerdlow et al., 2006). It is conceivable that
those with normal (to superior) sensorimotor gating are
able to remain focussed on the task at hand and not be
distracted by the voices, since they feel more able to
exert control and dismiss them. While the presence of
auditory hallucinations in patients with schizophrenia
may well be explained by a self-monitoring and
language-related deficit (Frith, 1992), our findings
suggest that their perceived controllability is a function
of their information processing characteristics, more
specifically sensorimotor gating.
The observation that a deficit in PPI was present
across both AH+ and AH− groups suggests that PPI
deficit in schizophrenia is susceptible to multiple state-
and trait-related influences (reviews, Braff et al., 2001;
Kumari and Ettinger, 2005). It is highly unlikely that a
single deficit or a specific symptom dimension will
explain PPI deficit in the schizophrenia population as a
whole.
Two other findings of our study also deserve some
comment. First, hearing voices with a high degree of
negative content was associated with a high pulse-alone
amplitude in the AH+ group. This is not surprising
given that such patients are likely to experience
heightened anxiety and anxiety states are well known
to potentiate the startle response (review, Grillon, 2002).
The positive correlations found between the anxiety(G2) and tension (G4) items of the PANSS and high
mean pulse-alone amplitude further suggest that the
association between high pulse-alone amplitude and
hearing voices with a high degree of negative content
was mediated by anxiety and tension. Second, we found
longer latencies to startle peak in the patient group. This
effect was significantly and more markedly present in
the AH+ group who also had more severe symptoms and
a (non-significantly) longer duration of illness than the
AH− group. The correlational analyses across all
patients confirmed that this effect was associated with
age (pulse-alone latency) and a longer duration of illness
(latencies to prepulse trials). Although the severity of
symptoms on the negative and general psychopathology
dimensions of the PANSS also showed some association
with latencies to prepulse trials, the duration of illness
accounted for most of the total variance. We had not
observed a schizophrenia-related deficit in the latency
measure in previous studies from our laboratory (e.g.
Kumari et al., 1999; 2000, 2002, 2005). The main
reason for this might be that they included much smaller
samples (nb45) of less symptomatic, and mostly
treatment-responsive, patients. A recent study by
Swerdlow and colleagues (2006) involving a large
cohort of patients (n=103) has shown longer latencies in
patients with schizophrenia; they found this effect to be
age-related. Age in their healthy sample, as in ours, did
not correlate significantly with latencies. The duration
of illness seems to be a stronger predictor of longer
latencies to prepulse trials than age in our patient
sample. It is, however, difficult to disentangle the effect
of duration of illness from that of ageing because the
longitudinal effects of illness unfolded with age (a
strong positive correlation between the two variables,
r=0.693; pb0.001). The longer latencies-lower 120-ms
PPI association found in the AH+ group was also, at
least in part, mediated by the duration of illness. The
possibility that patients with a longer duration of illness
and in regular contact with psychiatric services over the
longer term may have a more severe or different form of
the illness, reflected for example here as ‘slowed
processing of information’, deserves to be examined
further in future prospective studies. The positive
relationships that we found between longer latencies
and negative and general psychopathology subscales of
the PANSS also lend support to this possibility. It is
perhaps interesting to note that PPI and latency
measures had different clinical correlates in this study.
These two measures are known to be differentially
affected by manipulation of prepulse-to-pulse interval in
healthy populations (greater latency facilitation at 30-ms
prepulse-to-pulse interval but greater PPI at 120-ms
193V. Kumari et al. / Schizophrenia Research 101 (2008) 185–194prepulse-to-pulse interval) and considered to reflect
different processes (Graham, 1975). We did not detect a
schizophrenia-related deficit in habituation of the startle
response over the experimental session. This was
expected given that startle studies with the number of
trials used in the current study do not find such a deficit
(review, Braff et al., 2001). A much longer session with
about 100 startle trials is generally required to detect
such a deficit.
Finally, PPI is considered a well-validated animal
model for evaluating existing and potential new drug
treatments for schizophrenia (reviews, Swerdlow and
Geyer, 1998; Geyer et al., 2001). There is considerable
evidence that effective medication, more so with atypical
antipsychotics, can at least partially correct PPI deficit in
schizophrenia patients (Kumari et al., 1999, 2000, 2002,
2007b;Weike et al., 2000; Leumann et al., 2002;Meincke
et al., 2004; Swerdlow et al., 2006). The patients in the
present study were medicated with antipsychotic drugs
(including clozapine) most suited to them but still, as a
group, showed robust deficit at all prepulse intervals. The
most likely reason for this is that over 70% of our patients
were considered to have shown insufficient clinical
improvement by their treating clinicians and wished to
receive cognitive behaviour therapy in addition to their
usual drug treatment. Our findings thus raise the
interesting possibility that a lack of (or reduced)
improvement in PPI may help to characterize resistance
to pharmacotherapy in schizophrenia.
With replication, the present findings may have
theoretical and practical implications. At the theoretical
level, our findings suggest that subjective perceptions of
psychotic symptoms have specific neurophysiological,
and possibly functional outcome, correlates. Such
associations are unlikely to be detected with commonly
used (clinician-oriented and unidimensional) symptom
rating scales. At the clinical level, appraisals of control
over voices may be difficult to change since they seem
to be related to an underlying gating deficit.
4.1. Limitations
Our study suffers from two limitations. Firstly, the
majority of study participants, as is often the case in
studies of schizophrenia patients, were male. Secondly, a
large proportion of patients had remained distressed by
one or more of their symptoms despite stable medication
(and having tried several antipsychotics in the past) and
wished to receive cognitive behaviour therapy in
addition to their usual drug treatment. The findings
thus may not generalise to the schizophrenia population
on the whole.5. Conclusions
In conclusion, this study found that the presence of
auditory hallucinations is associatedwith a deficit in PPI if
the patients feel that they have no control over their
occurrence. This finding can be taken to suggest that
subjective perceptions of psychotic symptoms have spe-
cific neurophysiological, and possibly functional out-
come, correlates. It also found that hearing voices with a
high degree of negative content is associated with hyper-
startle responding possibly because such voices provoke
anxiety and tension in patients with schizophrenia.
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